Illumina Stock Price. Everything You Need To Know About The Illumina Stock!

What is Illumina Stock Price. Everything You Need To Know About The Illumina Stock!?

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 11,500 full-time employees. The company went IPO on 2000-06-28. The firm operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.

Illumina Stock Price. Everything You Need To Know About The Illumina Stock! performance

  • Employees

  • Company HQ

    San Diego
  • Website
  • ILMN Asset Type

    Common Stock
  • ILMN Market Capitalization

  • Earnings Per Share -27.61
  • Dividends Per Share 0
  • Dividend Date None
  • Quarterly Earnings Growth -0.965

How To Invest In Illumina Inc Stock From Malaysia, Thailand, Indonesia & Vietnam

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in international stocks? Look no further than Illumina, a frontrunner in the field of genetic sequencing. With Zorion, the investment platform built specifically to cater to investors like you, you can now access and invest in stocks like Illumina with ease. Illumina has revolutionized the healthcare industry by enabling researchers to study genetic variations, thus paving the way for innovations in personalized medicine and disease prevention. With Zorion's investment insights and recommendations, you can make well-informed decisions about your investments in Illumina. Additionally, Zorion provides resources and educational materials aimed at empowering investors from Malaysia, Thailand, Indonesia, and Vietnam to enhance their investment knowledge. Start investing in Illumina today through Zorion and be part of the future of healthcare.

How To Buy Illumina Inc Stock From Malaysia, Thailand, Indonesia & Vietnam

Interested in investing in Illumina? As a retail investor from Malaysia, Thailand, Indonesia, or Vietnam, you can now easily buy Illumina stock through Zorion's investment platform. Illumina, a leading genomics company, is revolutionizing healthcare and improving human health through its groundbreaking DNA sequencing technology. By investing in Illumina, you become part of the cutting-edge advancements in genomics and contribute to the future of personalized medicine. Zorion provides investment insights and recommendations to ensure you make informed decisions. Access resources and educational materials to expand your investment knowledge and embark on your Illumina investment journey with confidence. Start investing in Illumina today and be part of the genomics revolution.

Illumina Inc Analytics and Performance


Discover Illumina Inc (ILMN), a prominent player in the LIFE SCIENCES sector, specifically within the LABORATORY ANALYTICAL INSTRUMENTS industry. As a Common Stock, ILMN has a strong presence not only in the United States but also in various countries around the world, including its home base USA.

ILMN Financial Performance: Key Ratios and Market Indicators

As of the latest quarter ending 2023-06-30, ILMN boasts an EBITDA of 252000000 and a trailing price-to-earnings ratio (PE ratio) of -. The forward PE ratio stands at 72.99, which indicates stocks potential in earnings. ILMN's price-to-sales ratio (TTM) is 6.94, and the price-to-book ratio is 4.907. The company's enterprise value-to-revenue and enterprise value-to-EBITDA ratios are 7.21 and -9.22, respectively.

ILMN Stock Stability: Analyzing Marketing Volatility and Trends

ILMN stock performance showcases a beta of 1.123, highlighting moderate volatility. The 52-week high and low prices are 248.87 and 127.37, respectively, with a 50-day moving average of 164.75 and a 200-day moving average of 195.86. With 158300000 shares outstanding, ILMN demonstrates strong performance in the market.

ILMN Dividends: Current Yields and Shareholder Value

In terms of dividends, Illumina Inc has a dividend per share of 0 and a dividend yield of 0. The company's most recent dividend date was None, and the ex-dividend date was None. ILMN's financials reveal a book value of 41.49 and earnings per share (EPS) of -27.61, with a diluted EPS (TTM) of -27.61.

ILMN Revenue and Profitability: Unveiling the Company's Financial Strength

ILMN revenue per share (TTM) is 28.32, and its total revenue (TTM) amounts to 4461000000. The company's gross profit (TTM) is 3145000000. ILMN's profit margin stands at -0.938, while the operating margin (TTM) is -0.0386. The return on assets (TTM) and return on equity (TTM) are -0.0079 and -0.492, respectively.

ILMN Growth Prospects: Earnings Growth and Analyst Expectations

ILMN has experienced quarterly earnings growth (YOY) of -0.965, but its quarterly revenue growth (YOY) remains stagnant at 0.012. Analysts have set a target price of 205.33 for Illumina Inc stock.

Want To Buy Illumina Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: